Portola Pharmaceuticals, Inc. (PTLA)

33.70
NASDAQ
Prev Close 33.70
Day Low/High 0.00 / 0.00
52 Wk Low/High 14.81 / 45.60
Exchange NASDAQ
Shares Outstanding 66.82B
Market Cap 2.25B
Div & Yield N.A. (N.A)
Portola Shares Lower After Update on Anticoagulant Launch -- Biotech Movers

Portola Shares Lower After Update on Anticoagulant Launch -- Biotech Movers

The South San Francisco, Calif.-based firm said after the market close on Tuesday that the FDA has extended the review period for the company's prior approval supplement for Bevyxxa (betrixaban).

Portola Pharmaceuticals Supports 2017 World Thrombosis Day Campaign To Raise Awareness About The Persistent Risk Of Blood Clots

Portola Pharmaceuticals Supports 2017 World Thrombosis Day Campaign To Raise Awareness About The Persistent Risk Of Blood Clots

Portola and WTD Aim to Make VTE Protocol and Prevention a Priority Patient Safety Issue in Hospitals Across the United States

Southwest Airlines, Delta Air Lines, GE: 'Mad Money' Lightning Round

Southwest Airlines, Delta Air Lines, GE: 'Mad Money' Lightning Round

Jim Cramer is bullish on Southwest, Delta, General Electric, and Portola Pharmaceuticals.

Real Story Behind Tech's Selloff: Cramer's 'Mad Money' Recap (Tuesday 9/26/17)

Real Story Behind Tech's Selloff: Cramer's 'Mad Money' Recap (Tuesday 9/26/17)

From Apple's orders and funds liquidating winners to the slow-growing cloud narrative, Jim Cramer explains why he thinks this is selloff is really an opportunity.

Portola Shares Lower After Pricing Stock Offering - Biotech Movers

Portola Shares Lower After Pricing Stock Offering - Biotech Movers

The South San Francisco, Calif.-based firm said Sept. 12 it had priced its underwritten public offering of 6.35 million shares at $55 apiece.

Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Portola Pharmaceuticals, Inc. Investors (PTLA)

Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Portola Pharmaceuticals, Inc. Investors (PTLA)

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Portola Pharmaceuticals, Inc.

Norwegian Cruise Line, iRobot, Bank of America: 'Mad Money' Lightning Round

Norwegian Cruise Line, iRobot, Bank of America: 'Mad Money' Lightning Round

Jim Cramer is bullish on Norwegian Cruise Line, iRobot, Bank of America, Portola Pharmaceuticals and more.

What's Getting In This Rally's Way: Cramer's 'Mad Money' Recap (Thurs 8/24/17)

What's Getting In This Rally's Way: Cramer's 'Mad Money' Recap (Thurs 8/24/17)

Why is this market so lacking in follow-through? Jim Cramer says the guy in the White House is only part of the problem.

These Biotech Stocks are BOOMING

These Biotech Stocks are BOOMING

Perrigo leading the charge.

Cramer: Don't Risk It All on a Small Biotech Unless You're Willing to Lose It All

Cramer: Don't Risk It All on a Small Biotech Unless You're Willing to Lose It All

Without at least one approved drug, I am tempted to say you should just take a pass.

TheStreet Quant Rating: D- (Sell)